动物营养学报
動物營養學報
동물영양학보
Chinese Journal Of Animal Nutrition
2015年
10期
3047-3056
,共10页
胡如久%汪菲%李晶%姚军虎%杨小军
鬍如久%汪菲%李晶%姚軍虎%楊小軍
호여구%왕비%리정%요군호%양소군
一次注射法%15 N-亮氨酸%内源氨基酸损失量%GC-MS%公鸡
一次註射法%15 N-亮氨痠%內源氨基痠損失量%GC-MS%公鷄
일차주사법%15 N-량안산%내원안기산손실량%GC-MS%공계
single-administration method%15 N-leucine%endogenous amino acid losses%GC-MS%chicken
本研究旨在优化一次注射15 N-亮氨酸(15 N-Leu)示踪法检测鸡内源氨基酸( AA)损失量的适宜参数。试验一,研究气相色谱-质谱联用仪(GC-MS)测定Leu的15N丰度(APEL)的适宜参数,确定适宜的丰度测定范围;试验二,以48只艾维茵公鸡为对象,研究15 N-Leu的引入方式(肌肉注射和静脉注射)和剂量(10、20和30 mg/kg BW)对内源AA主要分泌源中APEL 的影响,旨在优化15 N-Leu的引入参数。结果显示:1) Leu的MTBSTFA衍生物在GC-MS上的最大特征碎片离子峰为质荷比(m/z)=200;当样品APEL<0.1%时,测定精准度(13.1%)和准确度(13.8%)较差;当样品 APEL 为0.1%~3.2%时,测定精准度和准确度分别为4.3%~9.7%和-5.9%~4.1%,所得到的同位素稀释曲线良好, R2为0.989;2)当15 N-Leu 引入剂量为20和30 mg/kg BW时,内源AA主要分泌源中APEL>0.1%;静脉注射的试鸡在注射部位出现淤血、外渗现象;3)15N-Leu 引入方式和剂量对内源 AA 主要分泌源的 APEL 不存在交互作用(P>0.05);各分泌源的APEL 均随引入剂量的增大而显著增加(P<0.05),当引入剂量为20 mg/kg BW时,各分泌源间的APEL 无显著差异( P>0.05);引入方式显著影响胰腺和肠黏膜的 APEL (P<0.05)。以上结果表明,15N-Leu引入剂量为20 mg/kg BW可满足GC-MS分析要求,同时选取肌肉注射可减少动物应激、简化操作程序,并降低成本。
本研究旨在優化一次註射15 N-亮氨痠(15 N-Leu)示蹤法檢測鷄內源氨基痠( AA)損失量的適宜參數。試驗一,研究氣相色譜-質譜聯用儀(GC-MS)測定Leu的15N豐度(APEL)的適宜參數,確定適宜的豐度測定範圍;試驗二,以48隻艾維茵公鷄為對象,研究15 N-Leu的引入方式(肌肉註射和靜脈註射)和劑量(10、20和30 mg/kg BW)對內源AA主要分泌源中APEL 的影響,旨在優化15 N-Leu的引入參數。結果顯示:1) Leu的MTBSTFA衍生物在GC-MS上的最大特徵碎片離子峰為質荷比(m/z)=200;噹樣品APEL<0.1%時,測定精準度(13.1%)和準確度(13.8%)較差;噹樣品 APEL 為0.1%~3.2%時,測定精準度和準確度分彆為4.3%~9.7%和-5.9%~4.1%,所得到的同位素稀釋麯線良好, R2為0.989;2)噹15 N-Leu 引入劑量為20和30 mg/kg BW時,內源AA主要分泌源中APEL>0.1%;靜脈註射的試鷄在註射部位齣現淤血、外滲現象;3)15N-Leu 引入方式和劑量對內源 AA 主要分泌源的 APEL 不存在交互作用(P>0.05);各分泌源的APEL 均隨引入劑量的增大而顯著增加(P<0.05),噹引入劑量為20 mg/kg BW時,各分泌源間的APEL 無顯著差異( P>0.05);引入方式顯著影響胰腺和腸黏膜的 APEL (P<0.05)。以上結果錶明,15N-Leu引入劑量為20 mg/kg BW可滿足GC-MS分析要求,同時選取肌肉註射可減少動物應激、簡化操作程序,併降低成本。
본연구지재우화일차주사15 N-량안산(15 N-Leu)시종법검측계내원안기산( AA)손실량적괄의삼수。시험일,연구기상색보-질보련용의(GC-MS)측정Leu적15N봉도(APEL)적괄의삼수,학정괄의적봉도측정범위;시험이,이48지애유인공계위대상,연구15 N-Leu적인입방식(기육주사화정맥주사)화제량(10、20화30 mg/kg BW)대내원AA주요분비원중APEL 적영향,지재우화15 N-Leu적인입삼수。결과현시:1) Leu적MTBSTFA연생물재GC-MS상적최대특정쇄편리자봉위질하비(m/z)=200;당양품APEL<0.1%시,측정정준도(13.1%)화준학도(13.8%)교차;당양품 APEL 위0.1%~3.2%시,측정정준도화준학도분별위4.3%~9.7%화-5.9%~4.1%,소득도적동위소희석곡선량호, R2위0.989;2)당15 N-Leu 인입제량위20화30 mg/kg BW시,내원AA주요분비원중APEL>0.1%;정맥주사적시계재주사부위출현어혈、외삼현상;3)15N-Leu 인입방식화제량대내원 AA 주요분비원적 APEL 불존재교호작용(P>0.05);각분비원적APEL 균수인입제량적증대이현저증가(P<0.05),당인입제량위20 mg/kg BW시,각분비원간적APEL 무현저차이( P>0.05);인입방식현저영향이선화장점막적 APEL (P<0.05)。이상결과표명,15N-Leu인입제량위20 mg/kg BW가만족GC-MS분석요구,동시선취기육주사가감소동물응격、간화조작정서,병강저성본。
The current study was conducted to optimize parameters of the 15 N-leucine single-administration method for measuring endogenous amino acid losses in chicken. Experiment 1 was designed to provide suitable parameters of gas chromatography-mass spectrometry ( GC-MS ) for determing 15 N-enrichment of leucine (APEL) and ascertain an appropriate scope of APEL in samples. Experiment 2 was carried out to optimize ad-ministration parameters of 15 N-leucine, using 48 Avian roosters to study the effects of administration methods (intramuscular injection and intravenous injection) and doses (10, 20 and 30 mg/kg BW) of 15N-leucine on 15 N-enrichment in main secretory sources of endogenous amino acids. The results showed as follows: 1 ) the biggest characteristic fragment ion peaks of MTBSTFA derivatives of leucine in GC-MS is m/z=200. Precision and accuracy of measurement were poor when APEL<0.1% in samples; measurement precision and accuracy respectively ranged from 4.3% to 9.7% and -5.9% to 4.1% when APEL ranged from 0.1% to 3.2%, and the standard curve of mixtures of natural and 15N-leucine showed a good linear relationship (R2=0.989). 2) The values of APEL in main secretory sources of endogenous amino acids were greater than 0.1% for 15N-leucine administration doses of 20 and 30 mg/kg BW. The experimental birds administrated 15N-leucine through intra-venous injection showed harmful stress including congestion and extravasation at the injection sites. 3 ) There were not administration methods and doses interaction effects ( P>0.05) of APEL in main secretory sources of endogenous amino acids. The values of APEL in main secretory sources of endogenous amino acids were in-creased significantly (P<0.05) with an increase of administration dose. The values of APEL among different secretory sources had no significant difference (P>0.05) at 15N-leucine administration doses of 20 mg/kg BW. However, the values of APEL in pancreas and intestinal mucosa were influenced significantly (P<0.05) by 15 N-leucine administration method. In conclusion, the 15 N-leucine administration doses of 20 mg/kg BW is se-lected to meet the requirements of GC-MS analysis, and intramuscular injection of 15 N-leucine is applied to re-duce harmful stress, simplify the operating procedure and reduce the cost.